- Home
- LAUR vs TFX Comparison
LAUR vs TFX Comparison
Compare LAUR & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LAUR | TFX |
|---|---|---|
| Founded | 1989 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.8B |
| IPO Year | 2015 | 1994 |
Fundamental Metrics
Financial Performance| Metric | LAUR | TFX |
|---|---|---|
| Price | $38.38 | $125.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 8 |
| Target Price | $39.63 | ★ $138.75 |
| AVG Volume (30 Days) | ★ 765.8K | 681.4K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.02% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.82 | ★ 2.08 |
| Revenue | $1,484,288,000.00 | ★ $1,992,713,000.00 |
| Revenue This Year | $14.58 | $15.97 |
| Revenue Next Year | $7.85 | $5.15 |
| P/E Ratio | ★ $46.32 | $60.08 |
| Revenue Growth | ★ 19.48 | N/A |
| 52 Week Low | $24.98 | $100.18 |
| 52 Week High | $40.93 | $145.00 |
Technical Indicators
Market Signals| Indicator | LAUR | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 58.60 | 40.35 |
| Support Level | $35.32 | $119.69 |
| Resistance Level | $38.10 | $137.48 |
| Average True Range (ATR) | 0.90 | 3.74 |
| MACD | 0.24 | -0.41 |
| Stochastic Oscillator | 85.96 | 39.65 |
Price Performance
Historical ComparisonAbout LAUR Laureate Education Inc.
Laureate Education Inc is an international community of universities. The company provides higher education programs and services to students through an international network of licensed universities and higher education institutions. Its reportable segments include Peru and Mexico, of which Mexico derives maximum revenue. Geographically, the company operates in Mexico, Peru and United States.
About TFX Teleflex Incorporated
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.